Imperagen

Andrew Almond, Andrew Currin, Tim Eyes, Rob Wilson
Seed
exited
 
LinkedIn

Imperagen is building an integrated, ML-driven robotic lab enabling the ultra-rapid design of enzyme biocatalysts that improve the efficiency of industrial processes.

Imperagen is building a next-generation enzyme development platform that combines advanced ML, ultra-fast biophysics simulations, and an integrated robotics wet lab to rapidly identify high-quality catalysts. By systematically exploring the protein space, Imperagen transcends the slow, unpredictable limitations of directed evolution (DE), unlocking new possibilities in the $11tn chemical manufacturing market.

Imperagen is a spinout of the University of Manchester's Institute of Biotechnology, a world-leader in enzyme design and development that is partnered with the Institute of Protein Design in Seattle.